- Rui Henrique, Portuguese Oncology Institute
- Dan Jones, Quest Diagnostics Nichols Institute
- Ferdinando Mannello, University of Urbino
- Sandeep Mathur, All India Institute of Medical Sciences
- Karoly Szuhai, Leiden University Medical Center
- neil sebire, Great Ormond Street Hospital
- Elaine Zhang, BioMed Central
A population-based cohort study demonstrates that high HMG-CoA reductase expression is associated with less aggressive tumor characteristics in primary breast cancer patients.
Using next generation sequencing procedures, this novel screening method allows detection of BRCA1/2 mutation in formalin-fixed paraffin-embedded ovarian and breast tumor tissue.
BMC Clinical Pathology is an open access, peer-reviewed journal that considers articles on all aspects of autopsy and clinical forensic pathology, clinical biochemistry, cytogenetics, cytopathology, hematopathology, histopathology, and medical microbiology (including virology, parasitology, and infection control).
BMC Clinical Pathology is part of the BMC series which publishes subject-specific journals focused on the needs of individual research communities across all areas of biology and medicine. We offer an efficient, fair and friendly peer review service, and are committed to publishing all sound science, provided that there is some advance in knowledge presented by the work.
BMC series - open, inclusive and trusted.
BMC series blog
- 18 May 2015
- The fascinating plants of BMC Plant Biology
- 01 May 2015
- April 2015: BMC Series Highlights